| Literature DB >> 17525034 |
Sanjay Sisodiya1, J Helen Cross, Ingmar Blümcke, David Chadwick, John Craig, Peter B Crino, Paul Debenham, Norman Delanty, Frances Elmslie, Mark Gardiner, Jeffrey Golden, David Goldstein, David A Greenberg, Renzo Guerrini, Michael Hanna, John Harris, Paul Harrison, Michael R Johnson, George Kirov, Dimitri M Kullman, Andrew Makoff, Carla Marini, Rima Nabbout, Lina Nashef, Jeffrey L Noebels, Ruth Ottman, Munir Pirmohamed, Asla Pitkänen, Ingrid Scheffer, Simon Shorvon, Graeme Sills, Nicholas Wood, Sameer Zuberi.
Abstract
The Sixth Epilepsy Research Foundation workshop, held in Oxford in March 2006, brought together basic scientists, geneticists, epidemiologists, statisticians, pharmacologists and clinicians to consider progress, issues and strategies for harnessing genetics to improve the understanding and treatment of the epilepsies. General principles were considered, including the fundamental importance of clear study design, adequate patient numbers, defi ned phenotypes, robust statistical data handling, and follow-up of genetic discoveries. Topics where some progress had been made were considered including chromosomal abnormalities, neurodevelopment, hippocampal sclerosis, juvenile myoclonic epilepsy, focal cortical dysplasia and pharmacogenetics. The ethical aspects of epilepsy genetics were reviewed. Principles and limitations of collaboration were discussed. Presentations and their matched discussions are produced here. There was optimism that further genetic research in epilepsy was not only feasible, but might lead to improvements in the lives of people with epilepsy.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17525034 DOI: 10.1684/epd.2007.0107
Source DB: PubMed Journal: Epileptic Disord ISSN: 1294-9361 Impact factor: 1.819